Christian Ammitzbøll

7PUBLICATIONS
29CO-AUTHORS
Innate immunityPredictive and prognostic markersRespiratory diseasesRheumatology and arthritisCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2024
COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab.

Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels

|Jul 21, 2022
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.

Christian Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen

|Mar 02, 2022
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.

Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels

|Sep 03, 2021
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.

Lars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen

|Jul 17, 2021
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Christian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen

|May 31, 2021
Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.

Christian Ammitzbøll, Jakob Bøgh Andersen, Signe Risbøl Vils

Pageof 2

Frequent Collaborators

5 joint publications

Anne Troldborg

5 joint publications

Christian Erikstrup

4 joint publications

Ellen-Margrethe Hauge

4 joint publications

Marianne Kragh Thomsen